AI brief of an SEC Form 8-K · Adient (ADNT)

Adient reports Q4 loss of $47 million as sales rise to $3.73 billion

Mixed Impact 3 of 5 earnings

Adient reported a fourth-quarter fiscal 2026 net loss attributable to Adient of $47 million, or $0.62 per diluted share, compared with net income of $18 million, or $0.22 per share, a year earlier. Net sales rose to $3.73 billion from $3.69 billion, but restructuring and impairment costs increased to $74 million from $11 million. For the full year, the net loss narrowed to $17 million from $281 million, and adjusted diluted earnings per share were $1.87, down from $1.93.

Key points

  • Q4 net sales $3.73 billion vs. $3.69 billion a year earlier
  • Q4 net loss attributable to Adient $47 million ($0.62 per diluted share) vs. net income of $18 million ($0.22)
  • Q4 restructuring and impairment costs $74 million vs. $11 million; adjusted diluted EPS $0.52 in both periods
  • Full-year net loss attributable to Adient $17 million vs. $281 million; full-year adjusted diluted EPS $1.87 vs. $1.93

The filing

CompanyAdient (ADNT)
Form8-K, current report
Filed with the SECNov 4, 2026, 6:49 AM ET
Accession number0001670541-26-000114

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.